The Effects of DHA- and EPA-enriched Oils on Cognitive Function and Mood
NCT02763514, Not applicable, Completed, Northumbria University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | The Effects of DHA- and EPA-enriched Oils on Cognitive Function and Mood | ClinicalTrials.gov |
| NCT number | NCT02763514 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 337 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Northumbria University | ClinicalTrials.gov |
| Conditions | Cognitive Function | ClinicalTrials.gov |
| Interventions | 3 g PronovaPure 150:500 EE EU, 3 g PronovaPure 500:200 EE EU, 3 g Placebo | ClinicalTrials.gov |
| First posted | 2016-05-05 | ClinicalTrials.gov |
| Last updated | 2019-01-24 | ClinicalTrials.gov |
Registered outcomes 18
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Episodic memory | 26 weeks | An overall score for Episodic memory will be derived by calculating the average score from 6 separate standardised task outcomes (Zimmediate word recall accuracy + Zdelayed word recall accuracy + Zword recognition accuracy + Zpicture recognition accuracy - Zimmediate word recall errors - Zdelayed word recall errors)/6 | ClinicalTrials.gov |
| Primary | Subjective fatigue | 26 weeks | Subjective fatigue will be derived from the Fatigue subscale of the Profile of Mood States questionnaire | ClinicalTrials.gov |
| Secondary | Subjective overall mood disturbance | 26 weeks | Subjective overall mood disturbance is derived from the overall score of the Profile of Mood States questionnaire | ClinicalTrials.gov |
| Secondary | Subjective vigour | 26 weeks | Subjective vigour will be derived from the Vigour subscale of the Profile of Mood States questionnaire | ClinicalTrials.gov |
| Secondary | Subjective confusion | 26 weeks | Subjective confusion will be derived from the Confusion subscale of the Profile of Mood States questionnaire | ClinicalTrials.gov |
| Secondary | Subjective anger | 26 weeks | Subjective anger will be derived from the Anger subscale of the Profile of Mood States questionnaire | ClinicalTrials.gov |
| Secondary | Subjective tension | 26 weeks | Subjective tension will be derived from the Tension subscale of the Profile of Mood States questionnaire | ClinicalTrials.gov |
| Secondary | Subjective alertness | 26 weeks | Subjective alertness will be derived from an Alertness visual analogue scale presented following cognitive task performance | ClinicalTrials.gov |
| Secondary | Subjective mental fatigue | 26 weeks | Subjective mental fatigue will be derived from a Mental Fatigue visual analogue scale presented following cognitive task performance | ClinicalTrials.gov |
| Secondary | Numeric Working memory | 26 weeks | Reaction time (ms) | ClinicalTrials.gov |
| Secondary | Numeric Working memory | 26 weeks | Accuracy (%) | ClinicalTrials.gov |
| Secondary | Simple reaction time | 26 weeks | ClinicalTrials.gov | |
| Secondary | Stroop task | 26 weeks | Reaction time (ms) | ClinicalTrials.gov |
| Secondary | Stroop task | 26 weeks | Accuracy (%) | ClinicalTrials.gov |
| Secondary | Rapid visual information processing | 26 weeks | Reaction time (ms) | ClinicalTrials.gov |
| Secondary | Rapid visual information processing | 26 weeks | Accuracy (%) | ClinicalTrials.gov |
| Secondary | Verbal fluency | 26 weeks | Number correct | ClinicalTrials.gov |
| Other | Omega-3 index | 26 weeks | Omega-3 index is expressed as the sum of EPA and DHA as a percentage of total red blood cell fatty acids | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|---|---|
| 34113957 | DERIVED | PubMed |
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 4
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Rapid Visual Information Processing | Secondary outcome | ConductCognition |
| Simple Reaction Time | Secondary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
| Verbal Fluency | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)